CD47-SIRPα Binding Assay

HD Hehua Dai
AF Andrew J. Friday
KA Khodor I. Abou-Daya
AW Amanda L. Williams
SM Steven Mortin-Toth
MN Matthew L. Nicotra
DR David M. Rothstein
WS Warren D. Shlomchik
TM Takashi Matozaki
JI Jeffrey S. Isenberg
MO Martin H. Oberbarnscheidt
JD Jayne S. Danska
FL Fadi G. Lakkis
request Request a Protocol
ask Ask a question
Favorite

Flow-based mouse CD47-Fc (mCD47-Fc) (R&D Systems) binding assay was performed as previously described with some modifications (12). Briefly, spleen cells from indicated mouse strains were blocked with anti-CD16/32 (BD Biosciences) followed by pre-clustering of SIRPα with unconjugated P84 antibody (eBiosciences). Cells were then incubated with serial dilution of mCD47-Fc for 30 minutes followed by secondary staining with anti-human IgG1-PE (R&D systems). Control cells were prepared in the same fashion except that hIgG1 Fc (R&D systems) was used instead of mCD47-Fc. Flow cytometry was performed to measure mCD47-Fc binding to monocyte subset (CD45+LinLy6GCD11b+CD11cF480 cells). SIRPα expression was performed by staining cells with PE-conjugated P84 antibody (BD) under identical conditions as binding assay.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A